ONCS BRAS Share Price

Equities

ONCO3

BRONCOACNOR6

Market Closed - Sao Paulo 21:06:00 10/05/2024 BST 5-day change 1st Jan Change
6.98 BRL +15.37% Intraday chart for ONCS BRAS -3.99% -46.31%

Financials

Sales 2024 * 6.71B 1.3B 104B Sales 2025 * 7.66B 1.48B 119B Capitalization 3.55B 688M 54.98B
Net income 2024 * 463M 89.77M 7.17B Net income 2025 * 515M 99.85M 7.98B EV / Sales 2024 * 1.16 x
Net Debt 2024 * 4.26B 826M 66.05B Net Debt 2025 * 3.85B 746M 59.6B EV / Sales 2025 * 0.97 x
P/E ratio 2024 *
7.43 x
P/E ratio 2025 *
7.5 x
Employees -
Yield 2024 *
2.19%
Yield 2025 *
4.15%
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
1 day+15.37%
1 week-3.99%
Current month-5.16%
1 month-13.08%
3 months-36.49%
6 months-31.10%
Current year-46.31%
More quotes
1 week
5.38
Extreme 5.38
7.57
1 month
5.38
Extreme 5.38
7.93
Current year
5.38
Extreme 5.38
12.95
1 year
5.38
Extreme 5.38
13.00
3 years
4.03
Extreme 4.03
19.62
5 years
4.03
Extreme 4.03
19.62
10 years
4.03
Extreme 4.03
19.62
More quotes
Date Price Change Volume
10/05/24 6.98 +15.37% 6,100,600
09/05/24 6.05 -3.66% 17,750,100
08/05/24 6.28 -15.93% 15,302,800
07/05/24 7.47 +2.05% 3,088,500
06/05/24 7.32 +0.69% 2,502,300

Delayed Quote Sao Paulo, May 10, 2024 at 09:06 pm

More quotes
Oncoclinicas do Brasil Servicos Medicos SA is a Brazil-based company engaged in the outpatient medical services sector. The company provides of medical services focused on Oncology. The Company, since its foundation, in addition to acting directly in the treatment of cancer patients, has dedicated itself to the study and identification of the appropriate therapy opportunities for patients and the growth trends in the sector. The company holds interest in a number of subsidiaries, such as Centro de Quimioterapia Antiblastica e Imunoterapia SA, Centro Mineiro de Infusoes SA, and Centro Paulista de Oncologia SA.
Sector
-
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
6.98 BRL
Average target price
14.83 BRL
Spread / Average Target
+112.51%
Consensus